Wilate - Von Willebrand Factor/coagulation Factor Viii Complex (human)
Product Images NDC 67467-182

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Wilate - Von Willebrand Factor/coagulation Factor Viii Complex (human) (NDC 67467-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Octapharma Pharmazeutika Produktionsgesellschaft M.b.h., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image File (Img0001)

FDA Label Image

Image File (Img0002)

FDA Label Image

Image File (Img0003)

FDA Label Image

Image File (Img0004)

FDA Label Image

Image File (Img0005)

Image File (Img0005)
This is a table showing the Virus Reduction Factor achieved during different production steps for both enveloped and non-enveloped viruses. Some of the viruses listed include HIV-1, HAV, and PPV. The S/D Treatment step achieved the highest Virus Reduction Factor for enveloped viruses, while Ton-Exchange and Chromatography were also effective. Non-enveloped viruses were more difficult to eliminate, with TDH Treatment achieving the highest reduction factor. A Global Reduction Factor was also calculated for each virus type, with some achieving above 1000 reduction.*
FDA Label Image

Image File (Img0006)

Image File (Img0006)
This is a description of a medication called wilate 500U which is administered via intravenous injection. It is a human coagulation factor complex comprised of von Willebrand factor and coagulation factor VIII. The medication has been treated with solvent detergent and heat. The package contains a powder which must be reconstituted with a supplied diluent prior to injection. The medication does not contain any preservatives and has a maximum protein content of 75 mg. The product comes in a single-use vial and must be stored according to the instructions. The National Drug Code (NDC) for this product is 67467-152.01.*
FDA Label Image

Image File (Img0007)

Image File (Img0007)
This is a description of a pharmaceutical product for intravenous injection. It includes von Willebrand Factor/ESEE5 (2g) and Coagulation Factor VI Complex (Human) (52 Sl). It also mentions that it is for prescription only and should be reconstituted with the supplied diluent before injection. The product has a total protein content of up to 15.0 my and is manufactured by Eretmausa. There is no available information on how to store it.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.